JP Morgan Cazenove today reaffirms its overweight investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and cut its price target to 3200p (from 3500p).
JP Morgan Cazenove today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to underweight (from neutral) and raised its price target to 1850p (from...